Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-703P (RNA, U6 small nuclear 703, pseudogene) is a human pseudogene related to U6 small nuclear RNA, an essential component of the spliceosome. U6 snRNA is crucial for pre-mRNA splicing, but pseudogenes like RNU6-703P do not encode functional RNA and are generally considered non-coding, lacking known or direct biological activity. There is currently no evidence that RNU6-703P is involved in any diseases, physiological pathways, or that it represents a drug or biomarker target. It is not considered a receptor, enzyme, transporter, transcription factor, or any canonical druggable protein/gene family. Direct functional or clinical significance of RNU6-703P has not been described in the literature or major genomic databases[1][5]. Other U6 snRNA pseudogenes have been studied in genomics or cancer expression surveys, but RNU6-703P specifically is not reported to have regulatory, biomarker, or disease-promoting roles. U6 itself is critical for spliceosome function and gene expression regulation, but pseudogenes such as RNU6-703P remain mostly functionally uncharacterized[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 703, pseudogene (RNU6-703P).